|
CNOT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.881380E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.802600E-01 |
| Normal-vs-Stage2 |
4.046200E-01 |
| Normal-vs-Stage3 |
1.164370E-01 |
| Normal-vs-Stage4 |
8.062400E-01 |
| Stage1-vs-Stage2 |
4.019600E-01 |
| Stage1-vs-Stage3 |
1.211360E-01 |
| Stage1-vs-Stage4 |
8.103400E-01 |
| Stage2-vs-Stage3 |
5.126800E-01 |
| Stage2-vs-Stage4 |
7.489200E-01 |
| Stage3-vs-Stage4 |
4.421400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.227600E-01 |
| Normal-vs-AfricanAmerican |
4.917400E-01 |
| Normal-vs-Asian |
3.063800E-01 |
| Caucasian-vs-AfricanAmerican |
9.362000E-01 |
| Caucasian-vs-Asian |
1.550780E-01 |
| AfricanAmerican-vs-Asian |
3.676600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.234800E-01 |
| Normal-vs-Female |
6.442100E-03 |
| Male-vs-Female |
3.800700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.048200E-01 |
| Normal-vs-Extreme_Weight |
3.047800E-01 |
| Normal-vs-Obese |
3.948100E-02 |
| Normal-vs-Extreme_Obese |
6.925000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.343000E-01 |
| Normal_Weight-vs-Obese |
2.437700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.771800E-01 |
| Extreme_Weight-vs-Obese |
7.383500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.348000E-01 |
| Obese-vs-Extreme_Obese |
2.024000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.183900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.064630E-01 |
| Normal-vs-Age(61-80Yrs) |
9.356600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.290800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.247600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.604100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.267700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.404620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.871840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.577200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.493400E-01 |
| Normal-VS-Type2 PRCC |
5.667400E-01 |
| Normal-VS-KIRP CIMP |
3.358100E-02 |
| Normal-VS-Unclassified PRCC |
4.880200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.498400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.061290E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.642400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.976380E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.061250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.046000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.228400E-01 |
| Normal-vs-N1 |
3.506100E-02 |
| Normal-vs-N2 |
7.799400E-01 |
| N0-vs-N1 |
2.432300E-02 |
| N0-vs-N2 |
6.779000E-01 |
| N1-vs-N2 |
5.180600E-01 |
|
|
